Acute myeloid leukemia screening: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute myeloid leukemia}} | {{Acute myeloid leukemia}} | ||
{{CMG}} {{shyam}} | {{CMG}}; {{shyam}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== |
Latest revision as of 13:03, 11 April 2019
Acute myeloid leukemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute myeloid leukemia screening On the Web |
American Roentgen Ray Society Images of Acute myeloid leukemia screening |
Risk calculators and risk factors for Acute myeloid leukemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
There are currently no guidelines for screening for acute myeloid leukemia. Monitoring of the complete blood count is done routinely.
Screening
There are currently no guidelines for screening for acute myeloid leukemia. Routine monitoring of complete blood count (CBC) once yearly is sufficient for screening for hematologic diseases in general.[1]
References
- ↑ Rumi E, Cazzola M (2017). "Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms". Blood. 129 (6): 680–692. doi:10.1182/blood-2016-10-695957. PMC 5335805. PMID 28028026.